Steve Aselage - Director at Biocryst Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
BCRX on Nasdaq
All Insider Reports
All Insider Reports

Steve Aselage - trading volume in the past year for Biocryst Pharmaceuticals Inc

Holdings reported by Steve Aselage for Biocryst Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 70.2K $453K $6.46 Jun 12, 2024 Direct
Common Stock 2.5K $16.2K $6.46 Jun 12, 2024 By Trust
Automatic Stock Option Grant 49.9K Jun 12, 2024 Direct Common Stock

Transactions reported by Steve Aselage for Biocryst Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.